EA014068B1 - Фармацевтическая композиция, содержащая противогрибковый агент и активный ингредиент, выбранный из карвеола, тимола, эвгенола и карвакрола - Google Patents

Фармацевтическая композиция, содержащая противогрибковый агент и активный ингредиент, выбранный из карвеола, тимола, эвгенола и карвакрола Download PDF

Info

Publication number
EA014068B1
EA014068B1 EA200702482A EA200702482A EA014068B1 EA 014068 B1 EA014068 B1 EA 014068B1 EA 200702482 A EA200702482 A EA 200702482A EA 200702482 A EA200702482 A EA 200702482A EA 014068 B1 EA014068 B1 EA 014068B1
Authority
EA
Eurasian Patent Office
Prior art keywords
therapeutically active
active substance
carvacrol
fluconazole
antifungal agent
Prior art date
Application number
EA200702482A
Other languages
English (en)
Russian (ru)
Other versions
EA200702482A1 (ru
Inventor
Аднан Реммаль
Original Assignee
Адванст Сайентифик Дивелопментс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адванст Сайентифик Дивелопментс filed Critical Адванст Сайентифик Дивелопментс
Publication of EA200702482A1 publication Critical patent/EA200702482A1/ru
Publication of EA014068B1 publication Critical patent/EA014068B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA200702482A 2005-05-13 2006-05-15 Фармацевтическая композиция, содержащая противогрибковый агент и активный ингредиент, выбранный из карвеола, тимола, эвгенола и карвакрола EA014068B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2005/001317 WO2006120496A1 (fr) 2005-05-13 2005-05-13 Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l’ eugenol, le thymol, le borneol, et le carvacrol
PCT/IB2006/001329 WO2006120565A2 (fr) 2005-05-13 2006-05-15 Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l'eugenol, le thymol, le borneol, le carvacrol, et les i0n0nes alpha- et beta-.

Publications (2)

Publication Number Publication Date
EA200702482A1 EA200702482A1 (ru) 2008-04-28
EA014068B1 true EA014068B1 (ru) 2010-08-30

Family

ID=35427301

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702482A EA014068B1 (ru) 2005-05-13 2006-05-15 Фармацевтическая композиция, содержащая противогрибковый агент и активный ингредиент, выбранный из карвеола, тимола, эвгенола и карвакрола

Country Status (13)

Country Link
US (1) US20080214568A1 (enExample)
EP (1) EP1879654B1 (enExample)
JP (1) JP5410747B2 (enExample)
CN (1) CN101189044B (enExample)
BR (1) BRPI0610132B8 (enExample)
CA (1) CA2607561C (enExample)
DK (1) DK1879654T3 (enExample)
EA (1) EA014068B1 (enExample)
ES (1) ES2390472T3 (enExample)
MA (1) MA29907B1 (enExample)
PT (1) PT1879654E (enExample)
TN (1) TNSN07425A1 (enExample)
WO (2) WO2006120496A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2790054C2 (ru) * 2018-12-07 2023-02-14 Глобал Биолайф Инк. Композиция и способ осуществления контроля инфекционных заболеваний функциональными ароматизирующими веществами

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1806982T3 (en) 2004-09-28 2018-11-19 Avivagen Inc COMPOSITIONS AND PROCEDURES FOR PROMOTING WEIGHT ADMINISTRATION AND FOOD TRAFFIC
US10449247B2 (en) 2007-10-26 2019-10-22 Avivagen Inc. Compositions and methods for enhancing immune response
AU2010242502B2 (en) 2009-04-30 2016-11-10 Avivagen Inc. Methods and compositions for improving the health of animals
WO2011036048A1 (en) 2009-09-24 2011-03-31 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
EP2648681B1 (en) 2010-12-07 2015-01-07 Unilever N.V. An oral care composition
CN102550610B (zh) * 2010-12-07 2014-12-10 菲勒斯株式会社 含有从红松球果中提取的植物杀菌素的天然抗菌剂及包含它的水果病害防除原料
CN103347407A (zh) * 2011-02-07 2013-10-09 弗门尼舍有限公司 抗真菌调味成分和组合物
EP2773315B1 (en) 2011-11-03 2015-07-08 Unilever N.V. A personal cleaning composition
JP5925605B2 (ja) * 2012-06-04 2016-05-25 花王株式会社 リパーゼ活性阻害剤、抗真菌剤、及びフケ抑制剤
IL251588B2 (en) * 2014-10-08 2024-09-01 Pacific Northwest Res Institute Methods and compositions for increasing the potency of antifungal agents
CN104642326B (zh) * 2015-02-16 2016-02-10 河南科技学院 一种含戊苯吡菌胺和香芹酚的杀菌组合物及其用途
CN109562182A (zh) 2016-06-02 2019-04-02 先进科学发展公司 包含桉树脑和阿莫西林的药物制剂
US10918647B2 (en) 2016-07-26 2021-02-16 University Of Southern California Selective bromodomain inhibition of fungal Bdf1
CN113116916B (zh) * 2021-05-25 2023-07-04 河北医科大学第二医院 一种治疗妇科疾病的药物组合物及其制备方法

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040192A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO2001015680A1 (en) * 1999-09-01 2001-03-08 Van Beek Global/Ninkov L.L.C. Composition for treatment of infections of humans and animals
WO2002056879A1 (en) * 2001-01-03 2002-07-25 Medpharma Plc Use of terpenes for the treatment of digestive tract infections
JP2002363070A (ja) * 2001-06-06 2002-12-18 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
WO2003049726A1 (en) * 2001-12-07 2003-06-19 Eden Research Plc Respiratory infection prevention and treatment with terpene-containing compositions
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
WO2004070017A2 (en) * 2003-02-04 2004-08-19 Bennes, Inc. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
WO2004089357A2 (en) * 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627153A (en) * 1994-01-14 1997-05-06 Xoma Corporation Anti-fungal methods and materials
US5294645A (en) * 1993-06-14 1994-03-15 Doyle E. Chastain Using menth-1-en-9-ol to kill bacteria, yeast, and fungi
CA2106032C (en) * 1993-09-13 1995-11-07 Gamini Weeratunga Methods for the manufacture of fluconazole and forms thereof, intermediates useful in the manufacture thereof, and combinations comprising fluconazole
US6319507B1 (en) * 1997-05-02 2001-11-20 Kobo Products, Inc. Agar gel bead composition and method
JP2002284702A (ja) * 2001-01-19 2002-10-03 Teika Seiyaku Kk 外用抗真菌製剤
US20040071757A1 (en) * 2001-11-20 2004-04-15 David Rolf Inhalation antiviral patch

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040192A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO2001015680A1 (en) * 1999-09-01 2001-03-08 Van Beek Global/Ninkov L.L.C. Composition for treatment of infections of humans and animals
WO2002056879A1 (en) * 2001-01-03 2002-07-25 Medpharma Plc Use of terpenes for the treatment of digestive tract infections
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
JP2002363070A (ja) * 2001-06-06 2002-12-18 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
WO2003049726A1 (en) * 2001-12-07 2003-06-19 Eden Research Plc Respiratory infection prevention and treatment with terpene-containing compositions
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
WO2004070017A2 (en) * 2003-02-04 2004-08-19 Bennes, Inc. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
WO2004089357A2 (en) * 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200382, Derwent Publications Ltd., London, GB; AN, 2003-880974, XP002438179 & JP 2002363070 A (YUTOKU YAKUHIN KOGYO KK), 18 December 2002 (2002-12-18), abstract *
HUSSAIN, AZHAR A. ET AL.: "Antifungal activity of Egyptian essential oils against some dermatophytes", AFRICAN JOURNAL OF MYCOLOGY AND BIOTECHNOLOGY (2003), 11(2), 1-20 CODEN: AJMBFV; ISSN: 1110-5879, 2003, XP008056733, page 16, paragraph 2; tables 9,10, page 2, paragraph 3 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2790054C2 (ru) * 2018-12-07 2023-02-14 Глобал Биолайф Инк. Композиция и способ осуществления контроля инфекционных заболеваний функциональными ароматизирующими веществами

Also Published As

Publication number Publication date
EP1879654B1 (fr) 2012-07-04
JP5410747B2 (ja) 2014-02-05
WO2006120496A1 (fr) 2006-11-16
PT1879654E (pt) 2012-08-29
CN101189044B (zh) 2011-12-07
BRPI0610132A2 (pt) 2012-09-25
JP2008540506A (ja) 2008-11-20
WO2006120565A2 (fr) 2006-11-16
CA2607561C (fr) 2014-02-04
CN101189044A (zh) 2008-05-28
WO2006120565A3 (fr) 2007-08-23
EA200702482A1 (ru) 2008-04-28
DK1879654T3 (da) 2012-08-20
CA2607561A1 (fr) 2006-11-16
US20080214568A1 (en) 2008-09-04
BRPI0610132B8 (pt) 2021-05-25
MA29907B1 (fr) 2008-11-03
BRPI0610132B1 (pt) 2020-08-11
EP1879654A2 (fr) 2008-01-23
TNSN07425A1 (fr) 2009-03-17
ES2390472T3 (es) 2012-11-13

Similar Documents

Publication Publication Date Title
JP2893035B2 (ja) 増強された抗菌剤組成物
Rapidis Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: perspectives from a maxillofacial surgeon
EA014068B1 (ru) Фармацевтическая композиция, содержащая противогрибковый агент и активный ингредиент, выбранный из карвеола, тимола, эвгенола и карвакрола
EA014069B1 (ru) Фармацевтическая композиция и её применение
CN107073124B (zh) 增效的抗微生物剂
US20180153840A1 (en) The compositions of glycerol and /or non-toxic amino acids for inhibiting and destroying biofilm, including related methods
US20040157837A1 (en) Combinations for the treatment of fungal infections
JP2008534224A (ja) デバイス内細菌感染処置用の改良された方法及び装置
CN113332277B (zh) 一种吡咯二酮化合物在制备抗真菌药物中的应用
US6660761B2 (en) Method of treatment for fungal infections with a synergistic formulation of antifungal agents
RU2195937C1 (ru) Комбинированный противотуберкулезный препарат (ризобутол)
US20180289656A1 (en) Compositions and methods to treat urinary tract infections
WO2004002430A2 (en) Combinations for the treatment of fungal infections
WO2018160104A1 (ru) Композиция антимикробных препаратов для лечения инфекционных заболеваний людей и животных и способ её применения
US20200237705A1 (en) Method to treat antimicrobial resistant candida
CN114306304A (zh) 4-羟基苯甲酸在制备改善心肌梗死的并发症的药物中的应用及药物
Borse et al. A concise review on mucormycosis
CN109069474B (zh) 增效的泰拉霉素
Luna et al. Potent antifungal effects of a new derivative of partricin A in a murine model of cerebral cryptococcosis
CA2479381C (en) A use of treatment for fungal infections with a synergistic formulation of antifungal agent, menthol and menthyl acetate
Fayez et al. SYNERGIC EFFECT OF COMBINATION THERAPY FOR TREATMENT OF COVID-19 ASSOCIATED MUCORMYCOSIS
WO2024229525A1 (en) Dysregulation of planktonic bacterial metabolism
CN118924720A (zh) 鱼腥草素钠和新鱼腥草素钠在耳念珠菌感染治疗中的应用
ES2732941T3 (es) Oleilfosfocolina para el tratamiento de la micosis
CN104997799B (zh) Drb在制备治疗细粒棘球蚴病药物中的应用

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU